Clinical Trial Update: Topical Tranexamic Acid (TXA) in Hip Fractures [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated topical tranexamic acid for hip fracture and associated anemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hip Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Sault Area Hospital | Conditions: Hip Fracture, Anemia | Phase 3 | Status: COMPLETED